Trial Profile
An Open-label, Single-arm Study to Evaluate the Safety and Antibody Titers Specific to the Rabies Virus in Healthy Subjects After Receiving a Single Dose of Intramuscularly Administered Rabies Immune Globulin (Human)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 Mar 2018
Price :
$35
*
At a glance
- Drugs Rabies immune globulin (Primary)
- Indications Rabies
- Focus Pharmacokinetics
- Sponsors Grifols
- 22 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 26 May 2014 New trial record